Ondansetron hydroch
Ended Awarded
- Contract number
- SPE2DP25F7825
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,086
Award facts
- Contract value 100% obligated
- $3,085.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,085.60 by the Defense Logistics Agency's Medical Supply Chain on June 4, 2025, for the supply of Ondansetron Hydrochloride. The contract employs firm fixed-price pricing with an ultimate completion date of June 16, 2025. This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which carries a ceiling value of $499,999,999 and remains valid through November 2026.
The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive positioning as a woman-owned small business in federal procurement. As a crucial supplier within the federal pharmaceutical supply chain, the contractor provides direct distribution of prescription drugs and medical supplies to Department of Defense healthcare facilities nationwide. Ondansetron Hydrochloride, an antiemetic commonly used in medical settings, will be delivered to support military health facility operations. This delivery order exemplifies the company's established role in fulfilling routine pharmaceutical supply requirements across the Defense Logistics Agency's extensive medical product portfolio.
Quick answers
Who was awarded contract SPE2DP25F7825?
SPE2DP25F7825 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 4, 2025.
How much is contract SPE2DP25F7825 worth?
The government has obligated $3,086 on SPE2DP25F7825.
Is contract SPE2DP25F7825 an order under another contract?
Yes. SPE2DP25F7825 is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F7825 competed?
The extent of competition for SPE2DP25F7825 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award